Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors.
BMC Endocr Disord
; 17(1): 32, 2017 Jun 08.
Article
in En
| MEDLINE
| ID: mdl-28595617
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Weight Loss
/
Diabetes Mellitus, Type 2
/
Dipeptidyl-Peptidase IV Inhibitors
/
Canagliflozin
/
Hypoglycemic Agents
Type of study:
Guideline
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
BMC Endocr Disord
Year:
2017
Type:
Article
Affiliation country:
United States